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Recently, there has been tremendous progress in characterizing the transcriptional network
regulating human embryonic stem cells (hESCs; MacArthur et al., 2009; Loh et al., 2011),
including those signaling events mediated by Oct4, Nanog, and Sox2. There is growing
interest in the epigenetic machinery involved in hESC self-renewal and differentiation. In
general, epigenetic regulation includes chromatin reorganization, DNA modiﬁcation, and
histonemodiﬁcation, which are not directly related to alterations inDNAsequences.Various
protein complexes, including Polycomb, trithorax, nucleosome remodeling deacetylase,
SWI/SNF, and Oct4, have been shown to play critical roles in epigenetic control of hESC
physiology. Hence, we will formally review recent advances in unraveling the multifaceted
role of epigenetic regulation in hESC self-renewal and induced differentiation, particularly
with respect to chromatin remodeling and DNA methylation events. Elucidating the molec-
ular mechanisms underlying the maintenance/differentiation of hESCs and reprogramming
of somatic cells will greatly strengthen our capacity to generate various types of cells to
treat human diseases.
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CHROMATIN REMODELING IN hESCs
Human embryonic stem cells (hESCs) feature the capability to
self-renew and to differentiate into all types of cells in humans.
Hence, they are therapeutically invaluable to treat major human
diseases, such as neurodegeneration, diabetes, and cardiovascu-
lar diseases. Recently, various approaches have been developed
to reprogram human somatic cells into induced pluripotent stem
cells (iPS cells; Yamanaka, 2009), providing a more abundant and
ethical-feasible source of progenitor cells that possess the capacity
of generating all types of human cells. However, the low efﬁ-
ciency of reprogramming terminally differentiated cells into iPS
cells has remained a major obstacle that prevents the wide appli-
cation of this technology in practical use. Hence, to achieve a
more comprehensive understanding of hESC biology and to pro-
mote application of the stem cell strategy in treating devastating
diseases, scientists have begun to explore new territories in the
context of hESC maintenance/differentiation, including the role
of chromatin remodeling.
It is well established that chromatin is composed of the
DNA component, the histone components being wrapped and
other related proteins. The dynamic assembly or disassembly of
DNA-histone structure is closely associated with many important
biological processes, such as DNA replication, DNA repair, and
transcription. Previous studies have shown that in hESCs, the
chromatin is in a less compact state globally than in terminally
differentiated cells (Meshorer et al., 2006). This loose compaction
of chromatin facilitates more dynamic and ﬂexible reorganization
during differentiation.
Many complexes, collectively referred to as chromatin remod-
elers that are mostly ATP-dependent, have been identiﬁed to
contribute to this less compact state. Chromatin remodelers
mediate the interaction between the DNA helix and histones,
hence regulating the accessibility of the DNA to transcription
factors and other machinery (Ho and Crabtree, 2010). Some well-
characterized remodeling complexes include SWI/SNF, NuRD,
Tip60/p400, and chromodomain helicase DNA binding protein
(CHD), which will be detailed in the following.
The SWI/SNF complex contains 9–12 subunits, among which
BAFs (including BAF47 and BAF155/170) play critical regula-
tory roles (Phelan et al., 1999) while Brg1 and Brm possess the
ATPase activity (de la Serna et al., 2006). Both Brg1 and Brm con-
tain bromodomains, hence they exhibit a preference for acetylated
histones. These proteins are ubiquitously utilized in mammalian
development, both in the maintenance of stem cell state and in
differentiation. In particular, Brg1 has been shown to interact
with the key regulators of pluripotency, Oct4, Sox2, and NANOG,
and exhibits a highly correlated genome-wide binding patterns
with these proteins (Liang et al., 2008; Ho et al., 2009), suggest-
ing a cooperative role of SWI/SNF complexes in keeping the cells
in the undifferentiated state. In addition, Brg1 binds to many
development-related genes exhibiting bivalent histone marks that
represent a “poised” status of activation. The bivalent histone
mark includes theH3K4me3 activation and theH3K27me3 repres-
sive modiﬁcations, which are particularly conﬁned to embryonic
stem cells (Bernstein et al., 2006). Hence Brg1 coverage of these
regions may ensure an efﬁcient and reversible repression of
differentiation-related genes. Once differentiation is irreversibly
initiated, BAF155 increases the H3K27me3 modiﬁcation at the
NANOG promoter and consequently causes condensation of the
local chromatin, hence repressing the expression of NANOG
(Schaniel et al., 2009). If BAF155 is depleted, the expression level
of NANOG will remain high so that differentiation of hESCs
will be signiﬁcantly impaired. Additionally, genome-wide loca-
tion analysis has found that BAF155 is also involved in depositing
on chromatin theH3K9me3mark, amodiﬁcation that contributes
to heterochromatin formation (Schaniel et al., 2009). Hence, even
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though co-existed in one SWI/SNF complex, Brg1 and BAF155
exert somewhat opposing effects on stem cell maintenance and
differentiation.
The Mi-2/nucleosome remodeling deacetylase (NuRD) com-
plex possesses both the APT-dependent chromatin remodeling
activity and the histone deacetylase activity (Denslow and Wade,
2007). The key components include chromodomain helicase
CHD3/4, deacetylase HDAC1/2, methy-CpG-binding proteins
Mbd3 and Mta1. They are involved in regulating pluripotency and
differentiation of ESCs via histone deacetylation. The deﬁciency of
Mbd3 leads to hyperacetylation and loss of ES pluripotency (Zhu
et al., 2009). For a similar complex that lacksMbd3,NODE, studies
have found that it interacts with NANOG and Oct4, and co-binds
to the NANOG/Oct4 target genes (Liang et al., 2008). Depletion
of Mta1 de-represses genes related to endoderm differentiation,
such as GATA6 and FoxA2 (Liang et al., 2008), indicating that an
intact NODE complex is required for suppression of premature
cell lineage commitment.
The Tip60/p400 complex also contains both an ATPase activity
and an acetyltransferase activity. In particular, the ATPase activity
is conferred by p400. Both activities are required for early embry-
onic development (Fazzio et al., 2008; Hu et al., 2009). Depletion
of Tip60/p400 leads to de-repression of genes, many of which
are important developmental regulators. Down-regulation of this
complex also impairs self-renewal of progenitor cells. Consistently,
p400 binding proﬁle coincides with those of H3K4me3 and biva-
lentmarks, a unique epigenetic feature inESCs (Fazzio et al., 2008),
implying that the Tip60/p400 complex is involved in maintaining
the pluripotent state of the cell.
A fourth major remodeling family is the CHDs. They con-
tain two chromodomains, hence exhibiting high afﬁnity for
methylated histones, especially H3K4me2/3 (Flanagan et al., 2005;
Marfella and Imbalzano, 2007; Sims et al., 2007). One member
of particular signiﬁcance is CHD1, which has been proved to
be required for maintaining a loose/open chromatin conforma-
tion in ESCs (Gaspar-Maia et al., 2009). Depletion of CHD1 leads
to heterochromatin formation characterized by high enrichment
of H3K9me3 and HP1γ, down-regulation of Oct4, and initia-
tion of neural development (Gaspar-Maia et al., 2009). Another
major member, CHD7, has been found critical for genera-
tion of migration-competent neural crest-like cell from hESCs
(Bajpai et al., 2010). In humans, mutation of CHD7 can also cause
a genetic disorder, CHARGE, which is characterized by severe
defects in many cell types at birth (Vissers et al., 2004), imply-
ing that CHD7 is indeed involved in embryonic development. It
is interesting to note that CHD7 harbors the BRK domain, which
is known to bind to CTCF (Allen et al., 2007), the protein play-
ing as insulators, hence raising the possibility that CHD7 may
help create a chromatin landscape with active (self-renewal and
pluripotency-related genes) and quiescent (cell lineage-speciﬁc
genes) segments.
DNA METHYLATION REGULATION IN hESC MAINTENANCE
AND DIFFERENTIATION
DNA methylation mainly occurs at the 5-C position of the CG
dinucleotide in mammalian cells, the occurrence of which is
inversely correlated with the GC content and CpG density (Bird,
2002; Illingworth and Bird, 2009). It represents a major epigenetic
regulation for many biological processes, such as gene transcrip-
tion, imprinting and transposon activity in embryonic stem cells,
germ cells, somatic cells, and tumor cells (Aranyi and Paldi, 2006;
Farthing et al., 2008; Xie et al., 2009).
DNA methylation is accomplished by three independent DNA
methyltransferases, DNMT1, DNMT3A, and DNMT3B (Kato
et al., 2007). In particular, DNMT3A and 3B are responsible for
de novo methylation events at cysteine while DNMT1 is involved
in the maintenance of the methylated status (Okano et al., 1999;
Chen et al., 2003). Depletion of DNMT members leads to embry-
onic lethality in the mouse model (Li et al., 1992; Okano et al.,
1998), and in in vitro culture, even though DNMT-knockout
cells can still self-renew, they lose the potentiality to differentiate
(Thomson et al., 1998; Okano et al., 1999), suggesting that DNMT
plays a more prominent role in pluripotency. DNA methylation
plays a critical epigenetic role in terms of gene expression (Loh
et al., 2011) and has different patterns in hESCs and differentiated
cells. In hESCs, the whole genome is relatively hypomethylated,
reﬂecting a more open and hyperdynamic nature of chromatin,
while in the latter, there is more DNA methylation genome-
wide suggesting a highly organized and a less active chromatin
conformation (Robertson, 2001; Bibikova et al., 2006; Gan et al.,
2007). Previous research has revealed an interesting inverse corre-
lation between CpG methylation and CpG dinucleotide density,
whereby densely packed CpG islands appear to be protected
from methylation (Kafri et al., 1992). Generally, CpG islands
near promoters of actively expressed genes are demethylated and
methylation at these sites is typically associated with gene repres-
sion during development (Bird, 2002). However, methylation
within the gene is usually associated with active transcription of
the gene, indicating that DNA methylation at different regions of
genes can play opposite roles (Laurent et al., 2010). In hESCs,
the CpG islands in the promoters of housekeeping genes and
key stem cell signature genes, such as Oct4, NANOG, TDGF1,
and Sox2, remain demethylated, hence permitting their active
expression to maintain the stem cell state (Weber et al., 2007;
Meissner et al., 2008). This notion is strengthened by studies using
the DNA methyltransferase inhibitors, 5-azacytidine and RG108,
in which cases the efﬁciency of reprogramming mouse ﬁbrob-
lasts to iPS cells were greatly enhanced (Mikkelsen et al., 2008;
Shi et al., 2008).
In a recent study, a substantial amount of non-CpG methyla-
tion was also uncovered in hESCs (Lister et al., 2009). However,
these non-conventional methylation simply disappeared upon
induced differentiation, indicating that ESCs uniquely employ
an additional methylation strategy to epigenetically regulate gene
expression. By pairwise comparison of hESC and fetal ﬁbroblasts,
the same group also observed a differentiation-related decrease
in CpG methylation as well as a positive correlation between
CpG methylation level in the gene body and gene expression in
differentiated cells.
In addition, DNA methylation occurred in repetitive sequences
has started to draw increasing attention from the ﬁeld, partially
due to the fact that in human cells, gene-coding regions only takes
up∼2% of the whole genome (Lander et al., 2001), while∼47% of
the DNA content can be classiﬁed into different types of repetitive
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elements – long-interspersed element (LINE), short-interspersed
element (SINE), SVA, LTR, satellite repeats, etc. A typical LINE
repeat occupies a ∼6 kb DNA sequence. In the human genome,
LINE repeats aremainly located outside coding sequences of genes,
such as promoters, introns, and untranslated regions. In hESCs,
they are constitutively transcribed into RNAs. Two open read-
ing frames, ORF1 and ORF2 (Scott et al., 1987), cannot only be
transcribed into RNAs, but also produce retrotranscriptase that
is essential for transposition of other retrotransposons, such as
Alu repeats. Additionally, ORF1 is transcribed and translated into
a protein with RNA binding and chaperon activity (Hohjoh and
Singer, 1997; Martin and Bushman, 2001). Alu repeats are evolved
from the 7SL RNA, and are typically 300 bp in length. There are
about one million copies of Alu repeats which account for ∼11%
DNA contents of the human genome (Rubin et al., 1994). They are
scattered within both coding and non-coding regions. In general,
these repetitive DNA elements had once been referred to as “junk
DNA” since no deﬁnitive functions had been uncovered for them.
However, recent work has suggested that they represent an over-
looked “treasure chest” with huge regulatory potentiality to exert
tremendous inﬂuence on cells, including the integrity of human
genome, embryogenesis, and tumorigenesis.
Signiﬁcantly, over half of CpGmethylation events in the human
genome is distributed among various types of DNA repeats (Cor-
daux and Batzer, 2009), but the methylation density varies greatly
among different classes of DNA repeats. In particular, about one-
third of theCpG islands are embedded inAlu repeatswhich exhibit
CpGdensity-correlatedmethylation,whereasCpG islands embed-
ded in LINE and LTR elements are generally hypermethylated
regardless of the GC content (Meissner et al., 2008).
Hypermethylation contributes to silencing of these repeats and
formation of heterochromatin. Since LINE,Alu and SVA repetitive
elements are frequently located in proximity to genes with protein
coding capacities (Cordaux and Batzer, 2009), these inhibitory
effects will most likely spread to the adjacent genes, thus epi-
genetically regulating gene expression in hESCs. Additionally, in
terminally differentiated human cells, repetitive elements are gen-
erally highly methylated and the quiescence of these repeats is
required for the integrity and stability of the cell genome (Donnelly
et al., 1999; Kato et al., 2007).
Recent studies have found that many repetitive elements are
hypermethylated in human pluripotent cells as compared to dif-
ferentiated cells (Meissner et al., 2008; Su et al., 2012), suggesting
an active role of these elements in maintaining the stem cell
state. The genome-wide analysis has shown that cells experience
dramatic changes in DNA methylation pattern during cell fate
commitment (Meissner et al., 2008; Lister et al., 2009; Nagae et al.,
2011). In particular, LINE, LTR, and satellite elements show a
more signiﬁcant differentiation-induced decrease in CpG methy-
lation than SINE, RNA repeats, and SVA repeats (Su et al., 2012).
This differential demethylation pattern can be partly explained
by the relative lower CpG density along the DNA sequences of
LINE and LTR (Su et al., 2012). Their study has further found
that the demethylated repetitive elements are mainly distributed
in intergenic regulatory regions and introns, but not in cod-
ing exons (Meissner et al., 2008; Su et al., 2012), suggesting a
potential epigenetic regulation of the adjacent coding region.
Indeed, genomic proﬁling of the demethylated repetitive ele-
ments has shown that most of the intron-embedded repeats are
methylated in hESCs but demethylated in differentiated cells. The
genes containing demethylated repetitive elements in their introns
generally exhibit a signiﬁcantly lower level of expression, sug-
gesting a synergized regulation of methylation in gene-embedded
repeats and gene transcription (Ball et al., 2009; Su et al., 2012).
Interestingly, in many human cancers, CpG hypomethylation
has been observed in repetitive DNA elements, LINE, SINE,
LTR, and satellite repeats (Rauch et al., 2008; Bollati et al., 2009;
Choi et al., 2009; Igarashi et al., 2010; Xie et al., 2010), reﬂecting
that tumorigenesis potentially shares some common epigenetic
regulation pathways with hESC maintenance and somatic cell
reprogramming.
CROSSTALK BETWEEN HISTONE MODIFICATION AND DNA
METHYLATION
Histonemodiﬁcations represent anothermajor ﬁeld of research on
epigenetic regulation of gene expression, and there aremany excel-
lent reviews recently published (Kato et al., 2011; Loh et al., 2011).
Hence, in the paper, we instead focus on the crosstalk between
DNA methylation and histone modiﬁcation.
Studies have identiﬁed an inverse relationship between H3K4
methylation and DNA methylation (Hashimshony et al., 2003;
Meissner et al., 2008). One study observed that methylation
at CpG-dense regions will inhibit the local Trithorex activity
that confers H3K4 methylation modiﬁcation (Bird, 2002). Since
H3K4me3 is usually associated with gene activation and present
at CpG islands largely enriched in promoter regions, these mutu-
ally exclusive effects may be part of the coordinative mechanism
underlying gene activation and silencing.
At the protein level, an interaction between methylcytosine
binding proteins, MeCP2/Mbd2, and HDAC/HMT has been
observed (Jones et al., 1998; Nan et al., 1998; Fuks et al., 2003).
However, a causal relationship has not yet been established. There
are also reports indicating that G9a and ESET, two methyltrans-
ferases for H3K9, can interact with DNMT3A/3B to facilitate local
methylation of DNA (Feldman et al., 2006; Li et al., 2006). EZH2,
an enzymatic component of the PRC2 complex involved in H3K27
methylation, can also interact with DNMTs to inﬂuence the DNA
methylation status (Viré et al., 2006).
CONCLUDING REMARKS
Recent studies on epigenetic landscape of embryonic stem
cells have gradually unraveled another layer of regulation on
pluripotency maintenance and differentiation. However, our cur-
rent knowledge of the spatiotemporal alterations in epigenetic
modiﬁcations that accompany ESC maintenance and transi-
tion/differentiation into functional somatic cells has remained
very limited, which prevents us from drawing a comprehensive
image of epigenetic regulatory network in hESCs. The crosstalk
between different epigenetic machinery, chromatin remodeling,
histone modiﬁcations, and DNA methylation, certainly warrants
future explorations to elucidate their respective roles in the epige-
netic regulation. We are also facing the challenge of integrating the
transcriptional regulation network and epigenetic network to fully
understand hESC self-renewal and differentiation. Furthermore,
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another major component of the central theorem, RNA, is grad-
ually coming into sight regarding the pluripotency maintenance
and development. Recent studies on non-coding RNAs and small
RNAs have suggested that some RNA species could regulate CpG
methylation at promoter regions and gene expression by inter-
acting with DNMT (Cernilogar et al., 2011; Rajasethupathy et al.,
2012), adding another twist to the already exciting research ﬁeld
of epigenetic regulation in hESCs.
REFERENCES
Allen, M. D., Religa, T. L., Freund, S.
M., and Bycroft, M. (2007). Solution
structure of the BRK domains from
CHD7. J. Mol. Biol. 371, 1135–1140.
Aranyi, T., and Paldi, A. (2006). The
constant variation: DNA methyla-
tion changes during preimplantation
development. FEBS Lett. 580, 6521–
6526.
Bajpai, R., Chen,D.A., Rada-Iglesias,A.,
Zhang, J., Xiong, Y., Helms, J., et al.
(2010). CHD7 cooperates with PBAF
to control multipotent neural crest
formation. Nature 463, 958–962.
Ball, M. P., Li, J. B., Gao, Y., Lee, J.
H., LeProust, E. M., Park, I. H., et al.
(2009). Targeted and genome-scale
strategies reveal gene-body methyla-
tion signatures in human cells. Nat.
Biotechnol. 27, 361–368.
Bernstein, B. E., Mikkelsen, T. S., Xie,
X., Kamal, M., Huebert, D. J., Cuff,
J., et al. (2006). A bivalent chromatin
structure marks key developmental
genes in embryonic stem cells. Cell
125, 315–326.
Bibikova, M., Chudin, E., Wu, B., Zhou,
L., Garcia, E. W., Liu, Y., et al. (2006).
Human embryonic stem cells have a
unique epigenetic signature. Genome
Res. 16, 1075–1783.
Bird, A. (2002). DNA methylation pat-
terns and epigenetic memory. Genes
Dev. 16, 6–21.
Bollati, V., Fabris, S., Pegoraro, V.,
Ronchetti, D., Mosca, L., Deliliers, G.
L., et al. (2009). Differential repet-
itive DNA methylation in multiple
myeloma molecular subgroups. Car-
cinogenesis 30, 1330–1335.
Cernilogar, F.M.,Onorati,M.C., Kothe,
G. O., Burroughs, A. M., Parsi, K. M.,
Breiling,A., et al. (2011). Chromatin-
associated RNA interference compo-
nents contribute to transcriptional
regulation in Drosophila. Nature 480,
391–395.
Chen, T., Ueda, Y., Dodge, J. E., Wang,
Z., and Li, E. (2003). Establishment
and maintenance of genomic methy-
lation patterns in mouse embryonic
stem cells by Dnmt3a and Dnmt3b.
Mol. Cell. Biol. 23, 5594–5605.
Choi, S. H., Worswick, S., Byun, H. M.,
Shear, T., Soussa, J. C., Wolff, E. M.,
et al. (2009). Changes inDNAmethy-
lation of tandem DNA repeats are
different from interspersed repeats in
cancer. Int. J. Cancer 125, 723–729.
Cordaux, R., and Batzer, M. A. (2009).
The impact of retrotransposons on
human genome evolution. Nat. Rev.
Genet. 10, 691–703.
de la Serna, I. L., Ohkawa, Y., and
Imbalzano, A. N. (2006). Chromatin
remodelling in mammalian differen-
tiation: lessons from ATP-dependent
remodellers. Nat. Rev. Genet. 7,
461–473.
Denslow, S. A., and Wade, P. A. (2007).
The human Mi-2/NuRD complex
and gene regulation. Oncogene 26,
5433–5438.
Donnelly, S. R., Hawkins, T. E., and
Moss, S. E. (1999). A conserved
nuclear element with a role in mam-
malian gene regulation. Hum. Mol.
Genet. 8, 1723–1728.
Farthing, C. R., Ficz, G., Ng, R. K.,
Chan, C. F., Andrews, S., Dean,
W., et al. (2008). Global mapping of
DNA methylation in mouse promot-
ers reveals epigenetic reprogramming
of pluripotency genes. PLoS Genet.
4, e1000116. doi: 10.1371/jour-
nal.pgen.1000116
Fazzio, T. G., Huff, J. T., and Panning,
B. (2008). An RNAi screen of chro-
matin proteins identiﬁes Tip60-p400
as a regulator of embryonic stem cell
identity. Cell 134, 162–174.
Feldman, N., Gerson, A., Fang, J., Li, E.,
Zhang, Y., Shinkai, Y., et al. (2006).
G9a-mediated irreversible epigenetic
inactivation of Oct-3/4 during early
embryogenesis. Nat. Cell Biol. 8,
188–194.
Flanagan, J. F., Mi, L. Z., Chruszcz, M.,
Cymborowski, M., Clines, K. L., Kim,
Y., et al. (2005). Double chromod-
omains cooperate to recognize the
methylated histone H3 tail. Nature
438, 1181–1185.
Fuks, F., Hurd, P. J., Wolf, D., Nan,
X., Bird, A. P., and Kouzarides,
T. (2003). The methyl-CpG-binding
protein MeCP2 links DNA methyla-
tion to histone methylation. J. Biol.
Chem. 278, 4035–4040.
Gan, Q., Yoshida, T., McDonald, O.
G., and Owens, G. K. (2007). Con-
cise review: epigenetic mechanisms
contribute to pluripotency and cell
lineage determination of embryonic
stem cells. Stem Cells 25, 2–9.
Gaspar-Maia, A., Alajem, A., Polesso, F.,
Sridharan, R., Mason, M. J., Heiders-
bach, A., et al. (2009). Chd1 regulates
open chromatin and pluripotency of
embryonic stem cells. Nature 460,
863–868.
Hashimshony, T., Zhang, J., Keshet, I.,
Bustin,M., andCeder,H. (2003). The
role of DNAmethylation in setting up
chromatin structure during develop-
ment. Nat. Genet. 34, 187–192.
Ho, L., and Crabtree, G. R. (2010).
Chromatin remodeling during devel-
opment. Nature 463, 474–484.
Ho, L., Ronan, J. L., Wu, J.,
Staahl, B. T., Chen, L., Kuo, A.,
et al. (2009). An embryonic stem
cell chromatin remodeling complex,
esBAF, is essential for embryonic stem
cell self-renewal and pluripotency.
Proc. Natl. Acad. Sci. U.S.A. 106,
5181–5186.
Hohjoh, H., and Singer, M. F.
(1997). Sequence-speciﬁc single-
strand RNA binding protein encoded
by the human LINE-1 retrotranspo-
son. EMBO J. 16, 6034–6043.
Hu, Y., Fisher, J. B., Koprowski, S.,
McAllister, D., Kim, M. S., and
Lough, J. (2009). Homozygous dis-
ruption of the Tip60 gene causes early
embryonic lethality. Dev. Dyn. 238,
2912–2921.
Igarashi, S., Suzuki, H., Niinuma, T.,
Shimizu, H., Nojima, M., Iwaki,
H., et al. (2010). A novel correla-
tion between LINE-1 hypomethyla-
tion and the malignancy of gastroin-
testinal stromal tumors. Clin. Cancer
Res. 16, 5114–5123.
Illingworth, R. S., and Bird, A. P. (2009).
CpG islands – “a rough guide”. FEBS
Lett. 583, 1713–1720.
Jones, P. L., Veenstra, G. J., Wade, P. A.,
Vermaak, D., Kass, S. U., Landsberger,
N., et al. (1998). Methylated DNA
and MeCP2 recruit histone deacety-
lase to repress transcription. Nat.
Genet. 19, 187–191.
Kafri, T., Ariel, M., Brandeis, M., She-
mer, R., Urven, L., McCarrey, J.,
et al. (1992). Developmental pattern
of gene-speciﬁc DNA methylation in
the mouse embryo and germ line.
Genes Dev. 6, 705–714.
Kato, Y., Kaneda, M., Hata, K., Kumaki,
K., Hisano, M., Kohara, Y., et al.
(2007). Role of the Dnmt3 family
in de novo methylation of imprinted
and repetitive sequences during male
germ cell development in the mouse.
Hum. Mol. Genet. 16, 2272–2280.
Kato, S., Yokoyama, A., and Fujiki,
R. (2011). Nuclear receptor coreg-
ulators merge transcriptional coreg-
ulation with epigenetic regulation.
Trends Biochem. Sci. 36, 272–281.
Lander, E. S., Linton, L. M., Birren, B.,
Nusbaum, C., Zody, M. C., Baldwin,
J., et al. (2001). Initial sequencing
and analysis of the human genome.
Nature 409, 860–921.
Laurent, L., Wong, E., Li, G., Huynh,
T., Tsirigos, A., Ong, C. T., et al.
(2010). Dynamic changes in the
human methylome during differen-
tiation. Genome Res. 20, 320–331.
Li, E., Bestor, T. H., and Jaenisch,
R. (1992). Targeted mutation of the
DNA methyltransferase gene results
in embryonic lethality. Cell 69,
915–926.
Li, H., Rauch, T., Chen, Z. X., Szabó,
P. E., Riggs, A. D., and Pfeifer,
G. P. (2006). The histone methyl-
transferase SETDB1 and the DNA
methyltransferase DNMT3A interact
directly and localize to promoters
silenced in cancer cells. J. Biol. Chem.
281, 19489–19500.
Liang, J.,Wan,M., Zhang,Y., Gu, P., Xin,
H., Jung, S. Y., et al. (2008). Nanog
and Oct4 associate with unique tran-
scriptional repression complexes in
embryonic stem cells. Nat. Cell Biol.
10, 731–739.
Lister, R., Pelizzola, M., Dowen, R.
H., Hawkins, R. D., Hon, G., Tonti-
Filippini, J., et al. (2009). Human
DNA methylomes at base resolution
show widespread epigenomic differ-
ences. Nature 462, 315–322.
Loh, Y. H., Yang, L., Yang, J. C., Li, H.,
Collins, J. J., and Daley, G. Q. (2011).
Genomic approaches to deconstruct
pluripotency. Annu. Rev. Genomics
Hum. Genet. 12, 165–185.
MacArthur, B. D., Ma’ayan, A., and
Lemischka, I. R. (2009). Systems biol-
ogy of stem cell fate and cellular
reprogramming. Nat. Rev. Mol. Cell
Biol. 10, 672–681.
Marfella, C. G., and Imbalzano, A. N.
(2007). The Chd family of chromatin
remodelers. Mutat. Res. 618, 30–40.
Martin, S. L., and Bushman, F. D.
(2001). Nucleic acid chaperone activ-
ity of the ORF1 protein from the
mouse LINE-1 retrotransposon. Mol.
Cell. Biol. 21, 467–475.
Meissner, A., Mikkelsen, T. S., Gu, H.,
Wernig, M., Hanna, J., Sivachenko,
A., et al. (2008). Genome-scale DNA
methylation maps of pluripotent
and differentiated cells. Nature 454,
766–770.
Meshorer, E., Yellajoshula, D., George,
E., Scambler, P. J., Brown, D. T.,
and Misteli, T. (2006). Hyperdy-
namic plasticity of chromatin pro-
teins in pluripotent embryonic stem
cells. Dev. Cell 10, 105–116.
Frontiers in Genetics | Epigenomics and Epigenetics November 2012 | Volume 3 | Article 238 | 4
“fgene-03-00238” — 2012/11/2 — 11:54 — page 5 — #5
Hu and Rosenfeld Epigenetic regulation of stem cells
Mikkelsen, T. S., Hanna, J., Zhang,
X., Ku, M., Wernig, M., Schorderet,
P., et al. (2008). Dissecting direct
reprogramming through integrative
genomic analysis. Nature 454, 49–55.
Nagae, G., Isagawa, T., Shiraki, N.,
Fujita, T., Yamamoto, S., Tsut-
sumi, S., et al. (2011). Tissue-speciﬁc
demethylation in CpG-poor promot-
ers during cellular differentiation.
Hum. Mol. Genet. 20, 2710–2721.
Nan, X., Ng, H. H., Johnson, C. A.,
Laherty, C. D., Turner, B. M., Eisen-
man, R. N., et al. (1998). Transcrip-
tional repression by the methyl-CpG-
binding protein MeCP2 involves a
histone deacetylase complex. Nature
393, 386–389.
Okano, M., Bell, D. W., Haber, D.
A., and Li, E. (1999). DNA methyl-
transferasesDnmt3a andDnmt3b are
essential for de novo methylation and
mammalian development. Cell 99,
247–257.
Okano, M., Xie, S., and Li, E. (1998).
Cloning and characterization of a
family of novel mammalian DNA
(cytosine-5) methyltransferases. Nat.
Genet. 19, 219–220.
Phelan, M. L., Sif, S., Narlikar, G. J., and
Kingston, R. E. (1999). Reconstruc-
tion of a core chromatin remodel-
ing complex fromSWI/SNF subunits.
Mol. Cell 3, 247–253.
Rajasethupathy, P., Antonov, I., Sheri-
dan, R., Frey, S., Sander, C., Tuschl,
T., et al. (2012). A role for neuronal
piRNAs in the epigenetic control of
memory-related synaptic plasticity.
Cell 149, 693–707.
Rauch, T. A., Zhong, X., Wu, X.,
Wang, M., Kernstine, K. H., Wang,
Z., et al. (2008). High-resolution
mapping of DNA hypermethylation
and hypomethylation in lung cancer.
Proc. Natl. Acad. Sci. U. S. A. 105,
252–257.
Robertson, K. D. (2001). DNA methyla-
tion, methyltransferases, and cancer.
Oncogene 20, 3139–3155.
Rubin,C.M.,VandeVoort, C.A., Teplitz,
R. L., and Schmid, C. W. (1994).
Alu repeated DNAs are differentially
methylated in primate germ cells.
Nucleic Acids Res. 22, 5121–5127.
Schaniel, C., Ang, Y. S., Ratnakumar,
K., Cormier, C., James, T., Bernstein,
E., et al. (2009). Smarcc1/Baf155 cou-
ples self-renewal gene repressionwith
changes in chromatin structure in
mouse embryonic stem cells. Stem
Cells 27, 2979–2991.
Scott, A. F., Schmeckpeper, B. J., Abdel-
razik, M., Comey, C. T., O’Hara, B.,
Rossiter, J. P., et al. (1987). Origin
of the human L1 elements: proposed
progenitor genes deduced from a
consensus DNA sequence. Genomics
1, 113–125.
Shi,Y., Desponts, C., Do, J. T., Hahm, H.
S., Schöler,H. R., and Ding, S. (2008).
Induction of pluripotent stem cells
from mouse embryonic ﬁbroblasts by
Oct4 and Klf4 with small-molecule
compounds. Cell Stem Cell 3,
568–574.
Sims, R. J. III, Millhouse, S., Chen, C.
F., Lewis, B. A., Erdjument-Bromage,
H., Tempst, P., et al. (2007). Recog-
nition of trimethylated histone H3
lysine 4 facilitates the recruitment
of transcription postinitiation factors
and pre-mRNA splicing. Mol. Cell 28,
665–676.
Su, J., Shao, X., Liu, H., Liu, S., Wu, Q.,
and Zhang, Y. (2012). Genome-wide
dynamic changes of DNA methyla-
tion of repetitive elements in human
embryonic stem cells and fetal ﬁbrob-
lasts. Genomics 99, 10–17.
Thomson, J. A., Itskovitz-Eldor, J.,
Shapiro, S. S., Waknitz, M. A.,
Swiergiel, J. J., Marshall, V. S., et al.
(1998). Embryonic stem cell lines
derived from human blastocysts. Sci-
ence 282, 1145–1147.
Viré, E., Brenner, C., Deplus, R.,
Blanchon, L., Fraga, M., Didelot,
C., et al. (2006). The Polycomb
group protein EZH2 directly con-
trols DNA methylation. Nature 439,
871–874.
Vissers, L. E., van Ravenswaaij, C. M.,
Admiraal, R., Hurst, J. A., de Vries,
B. B., Janssen, I. M., et al. (2004).
Mutations in a new member of the
chromodomain gene family cause
CHARGE syndrome. Nat. Genet. 36,
955–957.
Weber, M., Hellmann, I., Stadler, M. B.,
Ramos, L., Pääbo, S., Rebhan, M.,
et al. (2007). Distribution, silencing
potential and evolutionary impact of
promoter DNA methylation in the
human genome. Nat. Genet. 39,
457–466.
Xie, H., Wang, M., BonaldoMde, F.,
Rajaram, V., Stellpﬂug, W., Smith,
C., et al. (2010). Epigenomic analysis
of Alu repeats in human ependymo-
mas. Proc. Natl. Acad. Sci. U.S.A. 107,
6952–6957.
Xie, H., Wang, M., BonaldoMde, F.,
Smith, C., Rajaram, V., Goldman,
S., et al. (2009). High-throughput
sequence-based epigenomic analysis
of Alu repeats in human cere-
bellum. Nucleic Acids Res. 37,
4331–4340.
Yamanaka, S. (2009). A fresh look at iPS
cells. Cell 137, 13–17.
Zhu, D., Fang, J., Li, Y., and Zhang,
J. (2009). Mbd3, a component of
NuRD/Mi-2 complex, helps main-
tain pluripotency of mouse embry-
onic stem cells by repressing tro-
phectoderm differentiation. PLoS
ONE 4, e7684. doi: 10.1371/journal.
pone.0007684
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 05 June 2012; accepted: 17
October 2012; published online: 05
November 2012.
Citation:HuQandRosenfeldMG (2012)
Epigenetic regulation of human embry-
onic stem cells. Front. Gene. 3:238. doi:
10.3389/fgene.2012.00238
This article was submitted to Frontiers in
Epigenomics and Epigenetics, a specialty
of Frontiers in Genetics.
Copyright © 2012 Hu and Rosenfeld.
This is an open-access article distributed
under the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in other
forums, provided the original authors and
source are credited and subject to any
copyright notices concerning any third-
party graphics etc.
www.frontiersin.org November 2012 | Volume 3 | Article 238 | 5
